NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

Then they should not have premarket promoted their One Product that is supposedly part of a platform technology going by the same trademarked name to the specialty that will prescribe that One Product, if approved.

How do you think Novacure will react to that or do you think FDA only takes the side of the newest development? What about Roche, that Belgian company and the other companies investigating rGBM products…does the harm in premarket promoting done to them and their mission not matter to FDA?

You all are the crazy misleading ones. You all think FDA cares about minor technicalities, bait and swith or illusionary tactics…they don’t. They call a spade a spade and their definition of a spade is what they choose it to be and they tend not to be conservative with that definition.

Let me put it to you another way, if they did not seek FDA approval on that bag then we may have a very, very big problem with our application….like sell to Merck for pennies on the dollar big.

Do you think LP would take that risk…now of all times, now?